SOPHiA GENETICS CSO sells shares for tax withholding
SOPHiA GENETICS SA Chief Scientific Officer Zhenyu Xu reported open-market sales of ordinary shares tied to tax withholding on recently vested restricted stock units.
Rhea-AI Filing Summary
SOPHiA GENETICS SA Chief Scientific Officer Zhenyu Xu reported open-market sales of ordinary shares tied to tax withholding on recently vested restricted stock units. The transactions covered a total of 5,100 shares at weighted average prices around $4.86 per share.
According to the disclosure, the sales were executed under a pre-established Rule 10b5-1 trading plan and are described as non-discretionary trades to satisfy tax obligations. Following these transactions, Xu directly holds 644,952 ordinary shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 2,400 | $4.8663 | $12K |
| Sale | Ordinary Shares | 2,700 | $4.852 | $13K |
Footnotes (3)
- F1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.67 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
restricted stock units financial
weighted average price financial
open market financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SOPHiA GENETICS (SOPH) report for Zhenyu Xu?
Were the SOPHiA GENETICS insider sales part of a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.